Insights Into Encompass Health (EHC) Q3: Wall Street Projections for Key Metrics

Analysts on Wall Street project that Encompass Health (EHC) will announce quarterly earnings of $0.94 per share in its forthcoming report, representing an increase of 9.3% year over year. Revenues are projected to reach $1.33 billion, increasing 10% from the same quarter last year.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.That said, let's delve into the average estimates of some Encompass Health metrics that Wall Street analysts commonly model and monitor.The average prediction of analysts places 'Revenues- Inpatient Rehabilitation' at $1.30 billion. The estimate points to a change of +10% from the year-ago quarter.Analysts forecast 'Revenues- Outpatient and other' to reach $32.97 million. The estimate points to a change of +24.9% from the year-ago quarter.The collective assessment of analysts points to an estimated 'Net patient revenue per discharge' of $21,135.79. The estimate is in contrast to the year-ago figure of $20,472.Based on the collective assessment of analysts, 'Total Discharges' should arrive at 61,412. The estimate is in contrast to the year-ago figure of 57,665.View all Key Company Metrics for Encompass Health here>>>Over the past month, Encompass Health shares have recorded returns of +0.2% versus the Zacks S&P 500 composite's +2.7% change. Based on its Zacks Rank #2 (Buy), EHC will likely outperform the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Encompass Health Corporation (EHC): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks